Against the motion: Lasers are superfluous for the surgical management of benign prostatic hyperplasia in the developing world.
Identifieur interne : 000513 ( PubMed/Curation ); précédent : 000512; suivant : 000514Against the motion: Lasers are superfluous for the surgical management of benign prostatic hyperplasia in the developing world.
Auteurs : Anil Varshney [Inde] ; Anshuman AgarwalSource :
- Indian journal of urology : IJU : journal of the Urological Society of India [ 1998-3824 ] ; 2009.
Abstract
Lasers have arrived in a big way for the management of benign prostatic hyperplasia. The most common ones in use are holmium, potassium titanyl phosphate (KTP) and thulium.They remove the prostatic adenoma either by way of enucleation or ablation. Backed by numerous studies that prove their safety, efficacy and durability, lasers score over TURP in several ways. Their use is associated with less blood loss, shorter catheter time and decreased hospital stay. The fluid absorption during laser prostatectomy is negligible and thus makes it safer for use in cardiac patients. Also there is no chance of a transurethral resection syndrome, the incidence of which is approximately 2% with TURP. Due to superior hemostatic capabilities and non interference lasers can be used in patients on anti coagulants, cardiac pacemaker. Another advantage of laser over TURP is its ability to deal with prostates that are larger in size especially holmium laser which has been used to enucleate glands more than 300 g in size thus completely avoiding the need for open prostatectomy. The amount of tissue removed with enucleation is more thus retreatment rates are less than that of TURP. The initial cost of laser is higher but its capability to treat stones, its use in high risk situations, less morbidity, short hospital stay, and durable results make it an attractive option to treat BPH even in the developing world.
DOI: 10.4103/0970-1591.56188
PubMed: 19881144
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: Pour aller vers cette notice dans l'étape Curation :000513
Links to Exploration step
pubmed:19881144Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Against the motion: Lasers are superfluous for the surgical management of benign prostatic hyperplasia in the developing world.</title><author><name sortKey="Varshney, Anil" sort="Varshney, Anil" uniqKey="Varshney A" first="Anil" last="Varshney">Anil Varshney</name><affiliation wicri:level="1"><nlm:affiliation>RG Stone Urology and Laparoscopy Hospital, F 12, East of Kailash, New Delhi - 110 065, India.</nlm:affiliation><country xml:lang="fr">Inde</country><wicri:regionArea>RG Stone Urology and Laparoscopy Hospital, F 12, East of Kailash, New Delhi - 110 065</wicri:regionArea></affiliation></author><author><name sortKey="Agarwal, Anshuman" sort="Agarwal, Anshuman" uniqKey="Agarwal A" first="Anshuman" last="Agarwal">Anshuman Agarwal</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2009">2009</date><idno type="doi">10.4103/0970-1591.56188</idno><idno type="RBID">pubmed:19881144</idno><idno type="pmid">19881144</idno><idno type="wicri:Area/PubMed/Corpus">000513</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000513</idno><idno type="wicri:Area/PubMed/Curation">000513</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000513</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Against the motion: Lasers are superfluous for the surgical management of benign prostatic hyperplasia in the developing world.</title><author><name sortKey="Varshney, Anil" sort="Varshney, Anil" uniqKey="Varshney A" first="Anil" last="Varshney">Anil Varshney</name><affiliation wicri:level="1"><nlm:affiliation>RG Stone Urology and Laparoscopy Hospital, F 12, East of Kailash, New Delhi - 110 065, India.</nlm:affiliation><country xml:lang="fr">Inde</country><wicri:regionArea>RG Stone Urology and Laparoscopy Hospital, F 12, East of Kailash, New Delhi - 110 065</wicri:regionArea></affiliation></author><author><name sortKey="Agarwal, Anshuman" sort="Agarwal, Anshuman" uniqKey="Agarwal A" first="Anshuman" last="Agarwal">Anshuman Agarwal</name></author></analytic><series><title level="j">Indian journal of urology : IJU : journal of the Urological Society of India</title><idno type="eISSN">1998-3824</idno><imprint><date when="2009" type="published">2009</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Lasers have arrived in a big way for the management of benign prostatic hyperplasia. The most common ones in use are holmium, potassium titanyl phosphate (KTP) and thulium.They remove the prostatic adenoma either by way of enucleation or ablation. Backed by numerous studies that prove their safety, efficacy and durability, lasers score over TURP in several ways. Their use is associated with less blood loss, shorter catheter time and decreased hospital stay. The fluid absorption during laser prostatectomy is negligible and thus makes it safer for use in cardiac patients. Also there is no chance of a transurethral resection syndrome, the incidence of which is approximately 2% with TURP. Due to superior hemostatic capabilities and non interference lasers can be used in patients on anti coagulants, cardiac pacemaker. Another advantage of laser over TURP is its ability to deal with prostates that are larger in size especially holmium laser which has been used to enucleate glands more than 300 g in size thus completely avoiding the need for open prostatectomy. The amount of tissue removed with enucleation is more thus retreatment rates are less than that of TURP. The initial cost of laser is higher but its capability to treat stones, its use in high risk situations, less morbidity, short hospital stay, and durable results make it an attractive option to treat BPH even in the developing world.</div></front></TEI><pubmed><MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE"><PMID Version="1">19881144</PMID><DateCreated><Year>2009</Year><Month>11</Month><Day>02</Day></DateCreated><DateCompleted><Year>2011</Year><Month>07</Month><Day>14</Day></DateCompleted><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1998-3824</ISSN><JournalIssue CitedMedium="Internet"><Volume>25</Volume><Issue>3</Issue><PubDate><Year>2009</Year><Month>Jul</Month></PubDate></JournalIssue><Title>Indian journal of urology : IJU : journal of the Urological Society of India</Title><ISOAbbreviation>Indian J Urol</ISOAbbreviation></Journal><ArticleTitle>Against the motion: Lasers are superfluous for the surgical management of benign prostatic hyperplasia in the developing world.</ArticleTitle><Pagination><MedlinePgn>409-12</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.4103/0970-1591.56188</ELocationID><Abstract><AbstractText>Lasers have arrived in a big way for the management of benign prostatic hyperplasia. The most common ones in use are holmium, potassium titanyl phosphate (KTP) and thulium.They remove the prostatic adenoma either by way of enucleation or ablation. Backed by numerous studies that prove their safety, efficacy and durability, lasers score over TURP in several ways. Their use is associated with less blood loss, shorter catheter time and decreased hospital stay. The fluid absorption during laser prostatectomy is negligible and thus makes it safer for use in cardiac patients. Also there is no chance of a transurethral resection syndrome, the incidence of which is approximately 2% with TURP. Due to superior hemostatic capabilities and non interference lasers can be used in patients on anti coagulants, cardiac pacemaker. Another advantage of laser over TURP is its ability to deal with prostates that are larger in size especially holmium laser which has been used to enucleate glands more than 300 g in size thus completely avoiding the need for open prostatectomy. The amount of tissue removed with enucleation is more thus retreatment rates are less than that of TURP. The initial cost of laser is higher but its capability to treat stones, its use in high risk situations, less morbidity, short hospital stay, and durable results make it an attractive option to treat BPH even in the developing world.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Varshney</LastName><ForeName>Anil</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>RG Stone Urology and Laparoscopy Hospital, F 12, East of Kailash, New Delhi - 110 065, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Agarwal</LastName><ForeName>Anshuman</ForeName><Initials>A</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>India</Country><MedlineTA>Indian J Urol</MedlineTA><NlmUniqueID>8510441</NlmUniqueID><ISSNLinking>0970-1591</ISSNLinking></MedlineJournalInfo><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>J Urol. 2002 Oct;168(4 Pt 1):1465-9</RefSource><PMID Version="1">12352419</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Urol. 2000 Jun;163(6):1730-3</RefSource><PMID Version="1">10799170</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Eur Urol. 2008 Apr;53(4):744-9</RefSource><PMID Version="1">17475395</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Eur Urol. 2008 Feb;53(2):382-89</RefSource><PMID Version="1">17566639</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>BJU Int. 2007 Sep;100(3):593-8; discussion 598</RefSource><PMID Version="1">17511771</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Curr Opin Urol. 2007 Jan;17(1):27-31</RefSource><PMID Version="1">17143108</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Eur Urol. 2006 Sep;50(3):563-8</RefSource><PMID Version="1">16713070</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>BJU Int. 2006 Jan;97(1):85-9</RefSource><PMID Version="1">16336334</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>BJU Int. 2006 Jun;97(6):1229-33</RefSource><PMID Version="1">16686717</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Urol. 2006 Apr;175(4):1428-32</RefSource><PMID Version="1">16516015</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Urology. 2006 Jan;67(1):80-3</RefSource><PMID Version="1">16413337</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Urol. 2006 Feb;175(2):537-40</RefSource><PMID Version="1">16406990</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Endourol. 2005 Dec;19(10):1196-8</RefSource><PMID Version="1">16359214</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>BJU Int. 2006 Jan;97(1):81-4</RefSource><PMID Version="1">16336333</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Endourol. 2005 Jun;19(5):550-4</RefSource><PMID Version="1">15989443</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Urol. 2005 Jul;174(1):210-4</RefSource><PMID Version="1">15947629</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Br J Urol. 1997 Feb;79(2):177-80</RefSource><PMID Version="1">9052466</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Urol. 1989 Feb;141(2):243-7</RefSource><PMID Version="1">2643719</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Urol. 2004 Aug;172(2):611-5</RefSource><PMID Version="1">15247744</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Urol. 2003 Oct;170(4 Pt 1):1270-4</RefSource><PMID Version="1">14501739</PMID></CommentsCorrections></CommentsCorrectionsList><OtherID Source="NLM">PMC2779973</OtherID></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2009</Year><Month>11</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2009</Year><Month>11</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2009</Year><Month>11</Month><Day>3</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pii">IndianJUrol_2009_25_3_409_56188</ArticleId><ArticleId IdType="doi">10.4103/0970-1591.56188</ArticleId><ArticleId IdType="pubmed">19881144</ArticleId><ArticleId IdType="pmc">PMC2779973</ArticleId></ArticleIdList></PubmedData></pubmed></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Terre/explor/ThuliumV1/Data/PubMed/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000513 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd -nk 000513 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Terre
|area= ThuliumV1
|flux= PubMed
|étape= Curation
|type= RBID
|clé= pubmed:19881144
|texte= Against the motion: Lasers are superfluous for the surgical management of benign prostatic hyperplasia in the developing world.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/RBID.i -Sk "pubmed:19881144" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd \
| NlmPubMed2Wicri -a ThuliumV1
| This area was generated with Dilib version V0.6.21. |  |